Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study.
Sacktor, Ned MD; Skolasky, Richard L. ScD; Seaberg, Eric PhD; Munro, Cynthia PhD; Becker, James T. PhD; Martin, Eileen PhD; Ragin, Ann MD; Levine, Andrew PhD; Miller, Eric PhD
86(4):334-340, January 26, 2016.
(Format: HTML, PDF)
Objective: To evaluate the frequency of HIV-associated neurocognitive disorder (HAND) in HIV individuals and determine whether the frequency of HAND changed over 4 years of follow-up.
Methods: The Multicenter AIDS Cohort Study (MACS) is a prospective study of gay/bisexual men. Beginning in 2007, all MACS participants received a full neuropsychological test battery and functional assessments every 2 years to allow for HAND classification.
Results: The frequency of HAND for the 364 HIV individuals seen in 2007-2008 was 33% and for the 197 HIV individuals seen at all time periods during the 2007-2008, 2009-2010, and 2011-2012 periods were 25%, 25%, and 31%, respectively. The overall frequency of HAND increased from 2009-2010 to 2011-2012 (p = 0.048). Over the 4-year study, 77% of the 197 HIV individuals remained at their same stage, with 13% showing deterioration and 10% showing improvement in HAND stage. Hypercholesterolemia was associated with HAND progression. A diagnosis of asymptomatic neurocognitive impairment was associated with a 2-fold increased risk of symptomatic HAND compared to a diagnosis of normal cognition.
Conclusion: HAND remains common in HIV individuals. However, for the majority of HIV individuals on combination antiretroviral therapy with systemic virologic suppression, the diagnosis of HAND is not a progressive condition over 4 years of follow-up. Future studies should evaluate longitudinal changes in HAND and specific neurocognitive domains over a longer time period.
(C) 2016 American Academy of Neurology